Document Information


PMID 10417811  (  )
Title Cytosolic phospholipase A2 is induced in reactive glia following different forms of neurodegeneration.
Abstract Many recent studies have emphasized the deleterious role of inflammation in CNS injury. Increases in free fatty acids, eicosanoids, and products of lipid peroxidation are known to occur in various conditions of acute and chronic CNS injury, including cerebral ischemia, traumatic brain injury, and Alzheimer's disease. Although an inflammatory response can be induced by many different means, phospholipases, such as cytosolic phospholipase A(2) (cPLA(2)), may play an important role in the production of inflammatory mediators and in the production of other potential second messengers. cPLA(2) hydrolyzes membrane phospholipids and its activity liberates free fatty acids leading directly to the production of eicosanoids. We investigated the cellular localization of cytosolic phospholipase A(2) in the CNS following: (1) focal and global cerebral ischemia, (2) facial nerve axotomy, (3) human cases of Alzheimer's disease, (4) transgenic mice overexpressing mutant superoxide dismutase, a mouse model of amyotrophic lateral sclerosis, and (5) transgenic mice overexpressing mutant amyloid precursor protein, which exhibits age-related amyloid deposition characteristic of Alzheimer's disease. We show that in every condition evaluated, cytosolic phospholipase A(2) is present in reactive glial cells within the precise region of neuron loss. In conditions where neurons did not degenerate or are protected from death, cytosolic phospholipase A(2) is not observed. Both astrocytes and microglial cells are immunoreactive for cytosolic phospholipase A(2) following injury, with astrocytes being the most consistent cell type expressing cytosolic phospholipase A(2). The presence of cytosolic phospholipase A(2) does not merely overlap with reactive astroglia, as reactive astrocytes were observed that did not exhibit cytosolic phospholipase A(2) immunoreactivity. In most conditions evaluated, inflammatory processes have been postulated to play a pivotal role and may even participate in neuronal cell death. These results suggest that cytosolic phospholipase A(2) may prove an attractive therapeutic target for neurodegeneration. Medicine, Indianapolis, Indiana, USA.

NOTE: Color highlight is limited to the abstract and SciMiner text-mining mode. If you see much more identified targets below from "Targets by SciMiner Summary" and "Targets by SciMiner Full list", they may have been identified from the full text.



Targets by SciMiner Summary

HUGO ID Symbol Target Name #Occur ActualStr
620APPamyloid beta (A4) precursor protein (peptidase nexin-II, Alzheimer disease)3amyloid | amyloid beta protein |
9035PLA2G4Aphospholipase A2, group IVA (cytosolic, calcium-dependent)1cytosolic phospholipase a2 |
11179SOD1superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))1superoxide dismutase |

 


Targets by SciMiner Full list

HUGO ID Symbol Name ActualStr Score FlankingText
620APPamyloid beta (A4) precursor protein (peptidase nexin-II, Alzheimer disease)amyloid1.3amyotrophic lateral sclerosis and (5) 5 transgenic mice overexpressing mutant amyloid precursor protein which exhibits age-related amyloid deposition characteristic of Alzheimer's
620APPamyloid beta (A4) precursor protein (peptidase nexin-II, Alzheimer disease)amyloid1.3transgenic mice overexpressing mutant amyloid precursor protein which exhibits age-related amyloid deposition characteristic of Alzheimer's disease
9035PLA2G4Aphospholipase A2, group IVA (cytosolic, calcium-dependent)cytosolic phospholipase a21.0cytosolic phospholipase a2 is induced in reactive glia following different forms of neurodegeneration.
11179SOD1superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))superoxide dismutase1.0alization of cytosolic phospholipase a 2 in the cns following: 1 focal and global cerebral ischemia 2 facial nerve axotomy 3 human cases of alzheimer's disease 4 transgenic mice overexpressing mutant superoxide dismutase a mouse model of amyotrophic lateral sclerosis and 5 transgenic mice overexpressing mutant amyloid precursor protein which exhibits age related amyloid deposition characteristic of alzheimer's diseas
620APPamyloid beta (A4) precursor protein (peptidase nexin-II, Alzheimer disease)amyloid beta protein1.0amyloid beta protein precursor|isoenzymes|nerve tissue proteins|superoxide dismutase|phospholipases a|phospholipases a2|